The Asia Pacific has an opportunity to leapfrog the West when it comes to novel therapies and approaches to market access for Life Science companies.
One such approach is the introduction of a digital assistant or chatbot on a mobile phone to support the communication between Healthcare Professionals (HCPs) and the sales representatives of Life Sciences companies.
Chatbots can provide HCPs with easy and instant access to company-sponsored education, patient support programs, therapy side effects, medical query handling, adverse event reporting, trial updates and more.
But how should Life Science companies go about planning for and designing such a technology? What are the first steps on this digital transformation journey? And what are the key learnings and best practices they can glean from other organizations who have taken a similar path?
To find out more, please click here.